Abdominal Obesity: Clinical Trials

5 trials for Abdominal Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 21Completed 1

Follow Abdominal Obesity: new trials by email Literature Review of Abdominal Obesity trials Research Report on Abdominal Obesity

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Grain Exercise Trial - Whole Grain Versus no Grain With or Without Physiotherapy-promoted Exercise for Waist Loss
Diet A, Diet B, Physiotherapy - Abdominal Obesity, Cardiovascular Diseases
Phase 2 / Phase 3CompletedLund University1052010-08-012017-06-20
Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study)
Weight Loss Diets Plus Exercise - Overweight, Obese
Phase 3CompletedJohns Hopkins University772009-10-012013-04-04
The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients
Carvedilol CR + Lisinopril, Lisinopril + HCTZ - Abdominal Obesity, Hypertension
Phase 3CompletedSt. Paul Heart Clinic252007-04-012013-12-06
Rosuvastatin in Visceral Adiposity
Rosuvastatin, Placebo for rosuvastatin - Abdominal Obesity
Phase 3CompletedGöteborg University542006-05-012015-08-24
Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus
recombinant human growth hormone - Abdominal Obesity, Metabolic Syndrome
Phase 3CompletedGöteborg University401999-01-012008-10-29

Narrower conditions

Obesity, Abdominal (5)  ·  Hypertension (2)  ·  Obesity (2)  ·  Overweight (2)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)  ·  Metabolic Syndrome (1)  ·  Motor Activity (1)  ·  Sedentary Behavior (1)  ·  Stroke (1)  ·  Weight Loss (1)

Broader conditions

Body Weight (5)  ·  Nutrition Disorders (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Overnutrition (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Obesity (3)  ·  Overweight (3)  ·  Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Vascular Diseases (2)  ·  Behavior (1)  ·  Body Weight Changes (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)

Interventions

Exercise (2)  ·  Carvedilol (1)  ·  Diet, Reducing (1)  ·  Growth Hormone (1)  ·  Hydrochlorothiazide (1)  ·  Lisinopril (1)  ·  Physical Therapy Modalities (1)  ·  Rosuvastatin Calcium (1)  ·  Whole Grains (1)

Sponsors

Göteborg University (2)  ·  Johns Hopkins University (1)  ·  Lund University (1)  ·  St. Paul Heart Clinic (1)

Countries

Sweden (3)  ·  United States (2)

Top investigators

Aaron S Kelly, PhD (1)  ·  Anna Nilsson, MD, PhD (1)  ·  Claes Ohlsson, Professor (1)  ·  John-Olov Jansson, Prof (1)  ·  Kerry J Stewart, EdD (1)  ·  Kristjan Karason, MD, PhD (1)  ·  Staffan Lindeberg, MD PhD (1)

Results publications

PMID 38639002, PMID 41039470

NIH funding

R01HL092280 (1)